EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 22018D1172
Decision of the EEA Joint Committee No 234/2016 of 2 December 2016 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2018/1172]
Decision of the EEA Joint Committee No 234/2016 of 2 December 2016 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2018/1172]
Decision of the EEA Joint Committee No 234/2016 of 2 December 2016 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2018/1172]
OJ L 215, 23.8.2018, p. 30–31
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
In force
|
23.8.2018 |
EN |
Official Journal of the European Union |
L 215/30 |
DECISION OF THE EEA JOINT COMMITTEE
No 234/2016
of 2 December 2016
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2018/1172]
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,
Whereas:
|
(1) |
Commission Implementing Decision (EU) 2016/1174 of 15 July 2016 on the terms and conditions of the authorisation of a biocidal product containing difenacoum referred by Spain in accordance with Article 36 of Regulation (EU) No 528/2012 of the European Parliament and of the Council (1) is to be incorporated into the EEA Agreement. |
|
(2) |
Commission Implementing Decision (EU) 2016/1175 of 15 July 2016 on the terms and conditions of the authorisation of a biocidal product containing spinosad referred by the United Kingdom in accordance with Article 36 of Regulation (EU) No 528/2012 of the European Parliament and of the Council (2) is to be incorporated into the EEA Agreement. |
|
(3) |
Annex II to the EEA Agreement should therefore be amended accordingly, |
HAS ADOPTED THIS DECISION:
Article 1
The following points are inserted after point 12nnx (Commission Implementing Decision (EU) 2016/904) of Chapter XV of Annex II to the EEA Agreement:
|
‘12nny. |
32016 D 1174: Commission Implementing Decision (EU) 2016/1174 of 15 July 2016 on the terms and conditions of the authorisation of a biocidal product containing difenacoum referred by Spain in accordance with Article 36 of Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 193, 19.7.2016, p. 110). |
|
12nnz. |
32016 D 1175: Commission Implementing Decision (EU) 2016/1175 of 15 July 2016 on the terms and conditions of the authorisation of a biocidal product containing spinosad referred by the United Kingdom in accordance with Article 36 of Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 193, 19.7.2016, p. 113).’ |
Article 2
The texts of Implementing Decision (EU) 2016/1174 and (EU) 2016/1175 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Article 3
This Decision shall enter into force on 3 December 2016, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.
Done at Brussels, 2 December 2016.
For the EEA Joint Committee
The President
Bergdís ELLERTSDÓTTIR
(1) OJ L 193, 19.7.2016, p. 110.
(2) OJ L 193, 19.7.2016, p. 113.
(*1) No constitutional requirements indicated.